Many private mutations originate from the first few divisions of a human colorectal adenoma. by Kang, H et al.
Many Private Mutations Originate From The First Few Divisions 
Of A Human Colorectal Adenoma
Haeyoun Kang1, Matthew P. Salomon2, Andrea Sottoriva3, Junsong Zhao2, Morgan Toy4, 
Michael F. Press4, Christina Curtis5, Paul Marjoram2, Kimberly Siegmund2, and Darryl 
Shibata4
1
 Department of Pathology, CHA University, Seongnam-si, South Korea
2
 Department of Preventive Medicine, Keck School of Medicine of the University of Southern 
California, Los Angeles, California, USA
3
 Center for Evolution and Cancer, The Institute of Cancer Research, London, UK
4
 Department of Pathology, Keck School of Medicine of the University of Southern California, Los 
Angeles, California, USA
5
 Department of Medicine, Stanford University, Stanford, California, USA
Abstract
Intratumoral mutational heterogeneity (ITH) or the presence of different private mutations in 
different parts of the same tumor is commonly observed in human tumors. The mechanisms 
generating such ITH are uncertain. Here we find ITH can be remarkably well-structured by 
measuring point mutations, chromosome copy numbers and DNA passenger methylation from 
opposite sides and individual glands of a 6 cm human colorectal adenoma. ITH was present 
between tumor sides and individual glands, but the private mutations were side specific and 
subdivided the adenoma into two major subclones. Furthermore, ITH disappeared within 
individual glands because the glands were clonal populations composed of cells with identical 
mutant genotypes. Despite mutation clonality, the glands were relatively old, diverse populations 
when their individual cells were compared for passenger methylation and by FISH. These 
observations can be organized into an expanding star-like ancestral tree with co-clonal expansion, 
where many private mutations and multiple related clones arise during the first few divisions. As a 
consequence, most detectable mutational ITH in the final tumor originates from the first few 
divisions. Much of the early history of a tumor, especially the first few divisions, may be 
embedded within the detectable ITH of tumor genomes.
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What happens during the first few divisions that start the final growth of a visible human 
tumor is uncertain. The first few divisions may resemble most cell divisions, or may be 
unique, characterized perhaps by genomic instability with mutation bursts such as kataegis 
[1], chromothripsis [2], polyploidization [3], or centrosome duplications [4]. Very early 
growing human tumors are difficult to detect and it is uncertain if any removed small tumor 
would have actually progressed. However, it is possible to reconstruct the start of 
tumorigenesis by sampling genomes from different parts of the same tumor [5], potentially 
reconstructing even the first few tumor cell divisions of the last clonal expansion (Fig 1).
A recent study inferred that many human colorectal tumors are single co-clonal expansions 
(Big Bang tumorigenesis [6]) where most of the mutational intratumor heterogeneity (ITH) 
commonly observed in human tumors [7,8] originates from the first few divisions of growth. 
Here we illustrate with a human adenoma how extensive multi-regional sampling can 
reconstruct many details of an expanding population from the final topographic distributions 
of public (acquired before growth) and private (acquired during growth) mutations. Many 
“detectable” private mutations in the final tumor originate from the first few divisions 
because a point mutation must have a frequency >10% to be reliably detected by current 
exome sequencing [9]. For a simple exponential expansion at a diploid locus, frequencies in 
the final tumor are 50% for public mutations, 25% when a private mutation occurs during 
the first division, 12.5% during the second division and 6.25% during the third division.
The ancestral tree of an expanding population (Fig 1) predicts the adenoma will be 
composed of two distinct halves, each originating from one daughter of the first tumor cell 
division. Many related co-clones should be generated and scattered during growth, resulting 
in a star-like phylogeny. In the simplest scenario, tumor cells do not intermix, and any initial 
gland ITH created during the first few divisions would be dispersed during growth and gland 
fission [10] such that early private mutations will either be completely absent or present 
within all ~10,000 cells of the final glands. Alternatively, cell intermixing may be extensive, 
resulting in gland cells with different early private mutations (Fig S1). Most tumor 
mutations appear to be selectively neutral “passengers” [11] and in this analysis they are 
employed as lineage fate-markers of their co-clones. Here we demonstrate that the first few 
divisions of a human adenoma were unlike any other, with evidence of a mutation burst, 
polyploidization and the absence of cell intermixing.
Materials and Methods
Specimen
Two ~0.5 cm3 bulk samples (left side or A, and right side or B) from opposite sides of a 
fresh 6 cm adenoma (Adenoma K in Reference 6) were incubated in an EDTA-solution to 
release tumor glands [5]. Individual glands/fragments of ~10,000 cells were placed in 500 ul 
microfuge tube and frozen (−20C) until analysis [6]. Bulk specimens were collections 
(hundreds) of these glands. Normal colon was obtained more than 10 cm away from the 
tumor. The study received local institutional review board approval.
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DNAs from single glands or bulk samples were analyzed with SNP microarrays (Human 
OmniExpress, ~700,000 SNPs) using standard Illumina protocols and GenomeStudio with a 
quality threshold of 0.15. Glands with call rates <90% were not analyzed. Data were 
quantile-normalized and filtered using normal adjacent colon for a patient specific reference 
[12]. This algorithm converts BAF to mBAF (a diploid heterozygous site (AB) has an 
mBAF of 0, and a homozygous site has an mBAF of 1.0). Chromosome breakpoints were 
called by identifying segments of >100 SNPs with mBAF values >0.2. A linear 
transformation converted the Illumina CN data into tumor CN calls. Each segment was 
assigned a tentative CN: for mBAF>0.8 we set CN=1; mBAF <0.2, CN= 2; mBAF~0.3, 
CN= 3; and mBAF <0.2 but high raw CN values, CN= 4. A specimen specific linear 
regression (raw CN versus tentative CN) was used to call the tumor CN for each segment. 
Data are accessible via the ArrayExpress database under accession E-MTAB-2140
Exome sequencing, targeted resquencing and FISH
Bulk sequencing coverages were 24X for KA, 25X for KB and 40X for normal colon 
(Illumina TruSeq Exome Enrichment Kit, HiSeq 2000 platform, 100 bp paired end reads). 
Mutations were called using MuTect [9] at standard high confidence settings. Further 
filtering removed 76 mutations found within 200 bp of each other because they were 
commonly found in spuriously mutated genes such as CDC27 [13], and 9 of 9 such clustered 
mutations could not be validated by Sanger sequencing.
Targeted resequencing (AmpliSeq) was performed with PCR and IonTorrent sequencing. 
Gland DNA was the amount (10ng) recommended by the manufacturer. Poor quality calls 
(Q <20) were discarded. Mutation frequencies were the number of mutant calls divided by 
total calls. A threshold of > 5% was used to call a specimen mutation positive, and is based 
on an average “mutation” frequency at non-mutated bases of ~3% in our data.
Three sets of centromere (CH6, 7, 17) and gene probes (GOPC CH6q22.1, KDELR2 
CH7p22.1, HER2 CH17q12) were used on fixed tissue sections [6]. 20 nuclei from each 
gland were counted to calculate average gland CNs and diversities (Shannon Index [14]).
DNA passenger methylation studies
Bisulfite treated gland DNA was amplified at two X-chromosome passenger loci (BRS and 
LOC) as previously described [5]. A total of 24 epialleles were analyzed at each locus per 
gland. The mitotic age of the adenoma was estimated using epiallele pairwise distances and 
age curves previously generated for 11 human colorectal cancers, which had mitotic ages 
(divisions since initiation) from 250 to 1,130 divisions [5].
Topographic mutation studies
Tumor regions (~2-5 glands) were microdissected using ink-blot protection [15] from five 
paraffin adenoma blocks. PCR with individual targeted resequencing primers was followed 
by Sanger sequencing. A peak threshold of 5% was used to call a region mutation positive.
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The adenoma, with a 0.2 cm focus of intramucosal carcinoma, was 6 cm in diameter and 
removed from a 50 year old male. Two bulk specimens (~0.5 cm3) were sampled from 
opposite sides, and tumor glands/fragments (~10,000 cells) were isolated by EDTA-washout 
[5]. Mutations/alterations are sub-classified based on when they were acquired (Fig 1). 
Public mutations are acquired between the zygote and the first tumor cell and appear in all 
final tumor cells. Early private mutations are acquired during the first few divisions after 
tumor initiation and appear in all cells on one tumor side. Late private mutations appear in 
only some cells on one tumor side.
Chromosome Copy Numbers (CNs)
Chromosome CNs were measured with SNP microarrays from the bulk samples (left side = 
“A”, and right side = “B”) and 8 individual glands (4 left and 4 right). The left side was 
predominantly triploid and the right side was predominantly diploid (Fig 2 with details in 
Fig S2). Therefore, CN ITH is present between adenoma sides but minimal within a side. 
Most chromosomes were intact with 26 segments (20 whole chromosomes). There were two 
public (5q and 20p) LOH regions and a single late private LOH region (in 17p) in one left 
side gland. By contrast, except for a 5q LOH region (for which both sides had CN = 1), CNs 
were different for every chromosome between the left and right glands (Fig 2C). This 
massive CN change was essentially a haploid reduplication (22 of 24 segments) with the 
addition of two other chromosome segments on the left tumor side.
Point Mutations
Bulk exome sequencing revealed 227 left side mutations and 233 right side mutations, of 
which 70 (30%) were found on both sides. Subsets of these mutations (N= 55) were 
resequenced (AmpliSeq) from 12 different glands (6 left and 6 right) and both bulk 
specimens to an average depth of 754 reads (minimum of 20 reads). There were 13 public 
mutations (including a stop mutation in APC, Q789*) and 42 private mutations, with 24 
private mutations on the left tumor side and 18 private mutations on the right side. Similar to 
the CN data and consistent with a lack of adenoma cell intermixing, private mutations were 
side-specific and never found on both adenoma sides (Fig 3A). Six left side early private 
mutations were on two of three chromosome copies, consistent with mutation acquisition 
followed by chromosome reduplication (Fig 3A).
The gland mutation data (Fig 3A) construct a parsimonious tree without homoplasy (Fig 
3B). The significance of this tree is uncertain because the real adenoma tree has a single 
common ancestor and billions of tips representing the billions of present day cells. We 
propose that this tree approximates the first few adenoma divisions, where branches 
represent the genotypes of the first few adenoma cells. This hypothesis was further tested by 
examining two predictions. If the mutations were acquired during the first few divisions, 
after growth they should be disseminated throughout the adenoma and become clonal within 
individual tumor glands.
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Detectable Mutations Are Widespread
The bulk regions (~0.5 cm3) each represent only ~2% of the volume of the 6 cm adenoma. 
To test whether the private mutations were localized or disseminated, select mutations (3 
public and 15 private) were Sanger sequenced from multiple microdissected tumor spots 
from five additional independently obtained tissue sections (Fig 3C, with details in Fig S3). 
The three public mutations were detected in nearly all (>90%) sampled tumor regions, and 
the left and right private mutations separated into distinct regional patches. Right private 
mutations were present throughout four tissue sections. The last tissue section was divided 
into two distinct halves, equally occupied by either left or right private mutations. Based on 
this seven region sample (five tissue sections and two bulk regions), the left and right early 
adenoma tree branches respectively formed ~20% and 80% of the final tumor (Fig 3C).
If the three tested early right mutations (CREB5, FBXO1, SF1) in Fig 3B were acquired in 
the same mitosis, they should co-localize in the tissue sections (see SOM). However, patch-
like regions with three distinct genotypes (CREB5+,SF1+, FBXO1+, FHAD1+, CHD7+ like 
the B1 gland genotype; CREB5+, SF1+, FBXO1+ like the B2 gland genotype; and 
CREB5+, SF1+ or a new “B0” genotype) were observed, subdividing the first right branch 
in Fig 3A into at least two divisions (CREB5 and SF1 mutation in one division, and then 
FBXO1). This sequence of mutation accumulation (Fig 3D) represents co-clonal expansion 
and not sequential clonal evolution because progeny of these first few divisions occupied 
large portions of the final tumor (Fig 3C), indicating a growing star-like phylogeny (Fig 1). 
The detection of the private mutations throughout the seven tumor regions suggests that the 
first adenoma cell was correctly inferred (see supplementary online material).
Adenoma Glands Are Clonal For Detectable Point Mutations
In an expanding population, the earliest private mutations will become clonal in the final 
tumor glands because early tumor cells have millions of progeny. Gland cell composition 
can be estimated from mutation frequency (MF) and CN data. Gland MFs may vary from 
clonal frequencies because of many factors including ITH from cell intermixing, normal cell 
contamination and allele amplification/sequencing biases. Indeed public mutations, which 
should be clonal, had “bell-shaped” MF distributions centered about their expected clonal 
values. To control for these and other uncertainties, public and private MFs were compared 
(Fig 4). For the bulk specimens, private MFs were generally lower than expected compared 
to public MFs, consistent with private mutations in only some tumor cells. By contrast, both 
private and public average gland MFs were close to their expected clonal frequencies and 
not significantly different between private and public mutations. Therefore, as with the CN 
data, the point mutation data are consistent with clonal or “quantum” glands filled with cells 
of the same genotypes. Each gland has a well-defined genotype where a detectable private 
mutation is either absent or present in all gland cells. Mutation ITH is present between 
adenoma sides and between some neighboring glands, but disappears within a gland.
Adenoma Glands Are Diverse Cell Populations
Although glands will inevitably be clonal for early private mutations due to growth, ongoing 
sequential selection can also cause clonality. A difference between these scenarios is the 
“age” of the glands. With a single expansion, glands are created early and therefore will be 
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uniformly old or diverse populations and clonal for the early private mutations. With 
ongoing selection, glands can also be clonal for the private mutations but will be relatively 
young, minimally diverse populations because of recent bottlenecks. Gland diversity can be 
estimated by measuring differences between individual gland cells at highly unstable 
genomic features such as chromosome CN and passenger methylation.
Prior DNA passenger methylation studies demonstrated that most CRCs are single 
expansions with relatively old and diverse glands [5]. Similarly, the adenoma glands were 
diverse populations with multiple unique epialleles (Fig 5A) and, consistent with a single 
expansion, adenoma diversity appeared relatively uniform because gland diversities (defined 
by the number of unique gland patterns and gland pairwise distances) were not significantly 
different between opposite sides. The passenger DNA methylation diversity of this adenoma 
is comparable to that found in other CRCs, whose estimated mitotic ages ranged between 
250 and 1,100 divisions since tumor initiation [5].
Consistent with old and diverse gland populations, and chromosomal instability [16], CNs 
were different between adjacent adenoma cells within a single gland, with higher Shannon 
Diversity Index values compared to normal colon crypts for 5 of 6 FISH probes (Fig 5B). 
The observation that average gland ploidy is identical at most chromosome gland fragments 
within a side (Fig 2C) yet different between cells within a gland is more consistent with a 
single clonal expansion, with similar average integer gland CNs reflecting ancestry from an 
early side progenitor.
Private and Public Mutation Spectra Differ
Point mutation spectra can infer underlying mutational mechanisms [1]. Most public point 
mutations were acquired long ago in normal colon [17], whereas the private mutations arose 
in the early tumor microenvironment. The public and private mutation spectra differed (Fig 
5C), with private mutations having significantly more C>A transversions and significantly 
fewer A>G transitions. Consistent with mutations arising by the same mechanisms and 
within the same early microenvironment, there were no significant differences between the 
left and right private mutation spectra.
Reconstruction of the First Few Divisions
Using the early ancestral adenoma tree as a guide (Fig 3B), the genotypes of the first 
adenoma cell and the first “side” bulk progenitors can be inferred (Fig 6). Public mutations, 
accumulated over ~50 years between the zygote and tumor initiation, define the genotype of 
the first adenoma cell. A minority of the point mutations accumulated before tumor 
initiation, with two small regions of LOH. The only high frequency recurrent colorectal 
tumor driver mutation [11] was a truncating APC mutation with LOH.
Early private mutations found in all glands of one bulk sample define the genotype of the 
side bulk progenitor. Assuming a star-like phylogeny with exponential expansion and no cell 
intermixing, the last possible common ancestor for this tumor region (~ 2% each of the 6 cm 
adenoma) could arise by the fifth or sixth cell division after tumor initiation as (½)6 = 0.015 
and (½)5 = 0.031 (see SOM for details). During the up to six divisions between the first 
adenoma cell and a bulk side progenitor, there appeared to be a single coordinated haploid 
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duplication leading to near triploidy in the first progenitor left side cell (Fig 2). Six left side 
early private mutations were on two chromosome copies (Fig 3A), indicating they occurred 
before the haploid duplication. A scenario (see Discussion) that could generate both side 
progenitors after a few divisions includes an early point mutation burst (30 of the 42 
resequenced private mutations) and unscheduled whole-genome duplication with uneven 
cytokinesis (Fig 6). A mutation burst could also explain mutation spectra differences 
between the public and private mutations (Fig 5C).
Discussion
Tumors expand from single cells. Although tumor ancestry can be inferred from single 
specimens [18], here we illustrate how this process is facilitated by comparing genomes 
from multiple tumor regions. The ITH of this adenoma was well-structured, with detectable 
mutational ITH disappearing within glands and private mutations segregated by tumor side. 
Adenoma glands were clonal with respect to average chromosome CNs and detectable 
private mutations. Moreover, the glands were uniformly old cell populations with diverse 
passenger methylation patterns and CN differences between individual cells.
This structured ITH can be explained by a relatively simple star-like co-clonal expansion 
where most detectable mutational ITH essentially originates all at once during the first few 
adenoma cell divisions. If the first adenoma cell acquired a selective proliferative advantage, 
its immediate daughter cells should also be similarly capable, with the co-clonal expansion 
producing a star-like ancestral tree (Fig 1) and a spherical tumor. The left and right side 
progenitors had different genotypes and slightly different proliferation, with progeny of the 
left being predominantly triploid and producing about 20% of the adenoma. The patch-like 
subclone distribution in the final adenoma (Fig 3C) is reminiscent of normal growth where 
cells do not intermix, exemplified by distinct, contiguous G6PD colon crypt patches 
generated by X-linked inactivation during development in appropriate heterozygotes [19].
Stepwise clonal evolution could also sequentially generate multiple subclones within the 
same tumor. However, private mutations that arise after the initial expansion must undergo 
subsequent clonal expansion to become detectable. Stepwise clonal evolution becomes 
increasingly less plausible as multi-regional sampling uncovers increasingly more subclones 
because of the paucity of distinguishable driver mutations. Indeed, only a single canonical 
driver mutation in APC was detected in this adenoma. In addition, each new selective sweep 
would have to be large enough to confer detectability but still be limited enough to maintain 
ITH. A more parsimonious scenario is a single star-like expansion where many co-clones 
and their hitchhiking private passenger mutations arise early and inherently become 
detectable from growth. Selection occurs once at the start of tumorigenesis, which can help 
explain the paucity of driver mutations in this adenoma and most tumors [11]. Although not 
sampled, potentially stepwise progression could explain the small focus of carcinoma in this 
adenoma.
The generation of multiple distinct co-clones during the first few adenoma cell divisions can 
be explained by an unusual burst of private mutations and massive chromosomal 
missegregation. With a normal mutation rate (~10−9 per base per division), at most one new 
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exome mutation (~40 MB target) should arise per division, yet at least 30 new verified 
resequenced private mutations were inferred to arise during the first five to six divisions 
minimally required to form each small bulk tumor region. This mutation burst is not 
kategnesis [1] because the mutations were not clustered. The mutation spectra differed 
between the public and private mutations, with significantly fewer A>G transitions and 
greater C>A transversions, but no obvious mutation mechanism was evident.
A precedent for this type of division is the idea that polyploidization may be an important 
early step in tumorigenesis [3,4]. Tetraploidization has been observed in APC mutant cells 
[20,21] and an APC mutation with LOH was present in this first adenoma cell. DNA 
damage, telomere shortening and replication stress can also lead to unscheduled DNA 
duplication [3]. Multiple centrosome duplications and subsequent unequal cytokinesis could 
lead to a single division resulting in essentially a haploid gain in the left “triploid” side 
progenitor.
This analysis illustrates how growth embeds early human tumor histories within genomes 
taken from its different parts. Growth is a major signature embedded within ITH, where 
most detectable mutations occurred long ago [6]. The early tumor history is robust to many 
changes (mutations, small subclonal expansions) that occur later in tumorigenesis because 
all cells still retain early private mutations in their genomes. Tumors may evolve uniquely, 
and comprehensive, systematic sampling is imperative for understanding how individual 
tumors arose [22-26]. Further ancestral reconstructions of more human tumors should 
illuminate whether they are also single co-clonal expansions and if their first few divisions 
are also unusually chaotic, which may help inform better efforts for early cancer detection 
and prevention.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Reconstructing the first few adenoma cell divisions
Measurements of multiple glands from opposite adenoma sides allow reconstruction of this 
co-clonal expansion.
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Figure 2. SNP data
Heat map summarizing the SNP microarray data illustrating that the left and right adenoma 
sides are distinct, but CNs (adjusted to nearest integer values) are identical within a side 
(additional details in Fig S2).
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Figure 3. Point mutation analysis
A: Mutation resequencing data illustrate that public mutations (blue) were in all glands. 
Private mutations (green, left, or red, right) were isolated to each side. The glands are be 
classified into “genotypes” based on their mutations, with 4 and 2 different gland genotypes 
on the left and right sides. Yellow loci indicate mutations on more than one chromosome 
copy. Mutation frequency analysis (Fig 4) indicated a quantum clonal private mutation 
distribution -a private mutation is either absent from a gland or present in all cells of a gland. 
A resequenced mutation list is provided in Supplementary Table S1. B: Parsimonious 
ancestral tree manually inferred from the 6 indentified bulk gland genotypes (Fig 3A). 
Underlined loci indicate mutations further examined in five additional independent 
microscopic tissues sections. Most tested private mutations are also present in other parts of 
the adenoma. An additional early branch leading to a B0 subclone was inferred when 
sampling additional tissue sections (see below). C: Topographical distributions of 3 public 
and 15 private mutations tested with microdissection and Sanger sequencing in five 
additional tissue sections (details in Fig S3). Tumor section locations are inferred from the 
mutation data. The three public mutations were detected throughout the sections. There was 
no intermixing of the left and right private mutations in the tissue sections, with patch-like 
mutation topographies observed with the right side private mutations, which segregated into 
three distinct subclones (BO, B1, B2, see Fig 3D). The subdivision into left and right 
subclones was captured in one tissue slide. The left branch appeared to occupy about 20% of 
the final adenoma. Bars indicate 1 cm. D: The bulk specimen ancestral tree (Fig 3B) was 
further resolved with the five additional tissue sections, which identified one earlier 
subclone (B0), which lacked the FBXO1 private mutation. There were no tumor regions 
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without private mutations, suggesting that the first adenoma cell (yellow dot) was correctly 
inferred.
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Figure 4. Clonal adenoma glands
A: Public mutations (black triangles) illustrate variations between measured and expected 
clonal MF values. Comparisons between public and private (grey crosses) MFs in the bulk 
specimens illustrate that private mutations were significantly less frequent (t-test) at the 
triploid and diploid loci (*), indicating that the private mutations are in only some tumor 
cells. However, individual gland public and private MFs were not statistically different (t-
test) indicating that both public and private mutations (when present) were in all gland cells. 
B: Data plotted with respect to differences between expected and measured MFs at all loci 
reveal “bell shaped” distributions. In the bulk specimens, private mutations (grey bars) had 
significantly lower frequencies than public mutations (black bars), indicating that the private 
mutations are not in all tumor cells. In the gland specimens, public and private mutation 
frequencies are statistically indistinguishable, indicating that both public and private 
mutations (when present) are in all cells of a gland.
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Figure 5. Diverse adenoma glands
A: Numbers of unique epiallele patterns (among 24 sampled epialleles) per gland were not 
significantly different (t-test) between the sides (grey left adenoma side, black right 
adenoma side). Intra-gland pairwise distances were not significantly different between the 
sides (t-test). B: FISH revealed chromosome CNs differed between cells within the same 
gland. Adenoma Shannon diversity index values (grey) were higher (more diverse) than 
normal colon crypt values (black) for five of the six FISH probes and significantly higher (t-
test) for three probes (*). C: The mutation spectra of public exome mutations were 
significantly different from the private exome mutations (p= 2.0×10−7, chi-square test) with 
more C>A transversions and fewer T>C transitions. The differences between left and right 
private mutations were not significant (p=0.24).
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Figure 6. The first few inferred adenoma cell divisions
Potentially all of the early private mutations arose during the first few divisions, with 
genomic instability and a haploid duplication leading predominantly to triploidy on the left 
side.
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